DNA structural distortions induced by ruthenium-arene anticancer compounds

Area of Science:

• Organometallic Chemistry
• Computational Chemistry
• Molecular Biology

Background:

• Organometallic ruthenium(II)-arene (RA) compounds show potential in cancer therapy.
• RA-en and RA-pta are key classes of RA compounds studied for anticancer research.
• DNA interaction is a suspected mechanism for their therapeutic activity.

Purpose of the Study:

• Investigate DNA binding processes of RA-en and RA-pta complexes.
• Characterize structural DNA perturbations induced by these complexes.
• Elucidate atomistic details of RA-DNA interactions for rational drug design.

Main Methods:

• Ab initio molecular dynamics simulations.
• Classical molecular dynamics simulations.
• In vitro and in vivo studies (referenced).

Main Results:

• Both RA-en and RA-pta bind to the N7 atom of guanine bases in double-stranded DNA.
• DNA accommodates the complexes in the major groove.
• RA-en induces DNA backbone strain, leading to Watson-Crick base-pair disruption and local denaturation.
• RA-pta causes DNA helix bending towards the major groove, mimicking cisplatin's effect.

Conclusions:

• The study provides atomistic insights into how RA complexes interact with DNA.
• Different RA complexes induce distinct DNA structural changes.
• Findings support understanding the anticancer properties of RA compounds and guide future drug design.